Skip to main content

Key Product Details

Species Reactivity

Viral

Applications

Neutralization, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Goat IgG

Product Specifications

Immunogen

E. coli-derived recombinant viral MCV-type II Chemokine-like Protein

Specificity

Detects viral MCV-type II Chemokine-like Protein in direct ELISAs and Western blots.

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Endotoxin Level

<0.10 EU per 1 μg of the antibody by the LAL method.

Scientific Data Images for Viral MCV-type II Chemokine-like Protein Antibody

MCV‑type II Chemokine‑like Protein Inhibition of CCL1/I‑309-dependent Chemotaxis and Neutralization by Viral MCV‑type II Chemokine‑like Protein Antibody.

MCV‑type II Chemokine‑like Protein Inhibition of CCL1/I‑309-dependent Chemotaxis and Neutralization by Viral MCV‑type II Chemokine‑like Protein Antibody.

Recombinant Viral MCV-type II Chemokine-like Protein (Catalog # 697-M3) inhibits Recombinant Human CCL1/I-309 (Catalog # 272-I) induced chemotaxis in the BaF3 mouse pro-B cell line transfected with human CCR8 in a dose-dependent manner (orange line). The amount of cells that migrated through to the lower chemotaxis chamber was measured by Resazurin (Catalog # AR002). Inhibition of Recombinant Human CCL1/I-309 (20 ng/mL) activity elicited by Recombinant Viral MCV-type II Chemokine-like Protein (0.2 µg/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Viral MCV-type II Chemokine-like Protein Antigen Affinity-purified Polyclonal Antibody (Catalog # AF697). The ND50 is typically 5-20 µg/mL.

Applications for Viral MCV-type II Chemokine-like Protein Antibody

Application
Recommended Usage

Western Blot

0.1 µg/mL
Sample: Recombinant Viral MCV-type II Chemokine-like Protein (Catalog # 697-M3)

Neutralization

Measured by its ability to neutralize MCV-type II Chemokine-like Protein inhibition of CCL1/I-309-dependent chemotaxis in the BaF3 mouse pro-B cell line transfected with human CCR8. The Neutralization Dose (ND50) is typically 5-20 µg/mL in the presence of 0.2 µg/mL Recombinant Viral MCV-type II Chemokine-like Protein and 20 #ng/mL Recombinant Human CCL1/I-309.

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: MCV-type II Chemokine-like Protein

Molluscum contagiosum virus (MCV) is a human cutaneous poxvirus which causes benign proliferative lesions of the skin in normal and immunocompromised individuals. Based on endonuclease cleavage patterns of viral DNA, MCV isolates can be classified into two different types, MCV type I (MCVI) and MCV type II (MCVII). Like other DNA viruses such as poxviruses and herpesviruses, MCV has been shown to encode homologs of cellular immunomodulatory proteins. These viral proteins enable the virus to evade the host immune system and enhance the ability of the virus to propogate and survive.

MC148R2 is a CC chemokine-like protein encoded by a MCV type II gene. MC148R2 cDNA encodes a putative 104 amino acid (aa) protein containing a 24 aa signal peptide that is cleaved to produce an 80 aa mature protein. The mature protein shares 89% homology to the MCV type I chemokine-like protein, MC148R1. Compared to MIP-beta, MC148R2 retains the 4 conserved cysteine residues but has a 5 aa residue deletion at the amino-terminus region which is important for receptor activation. The MCV type I and type 2 proteins do not exhibit chemotactic properties, however these proteins have been shown in vitro to inhibit the monocyte chemotaxis induced by human MIP-1 alpha as well as the binding of radiolabeled I-309 to hCCR8 transfected cells.

References

  1. Krathwohl, M. et al. (1997) Proc. Natl. Acad. Sci. USA 94:9875.
  2. Senkevich, T. et al. (1996) Science 273:813.
  3. Dairaghi, D.J. et al. (1999) J. Biol. Chem. 274:21569.

Long Name

Molluscum Contagiosum Virus Type II

Alternate Names

MCVtype II

Additional MCV-type II Chemokine-like Protein Products

Product Documents for Viral MCV-type II Chemokine-like Protein Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Viral MCV-type II Chemokine-like Protein Antibody

For research use only

Loading...
Loading...
Loading...
Loading...